Adverse Event Reporting Gilead Oncology | GileadPro

For GB healthcare professionals only. This page contains promotional content
Adverse Event Reporting Prescribing Information

Adverse events should be reported.

For the UK, reporting forms and information can be found at www.mhra.gov.uk/yellowcard or via the Yellow Card app (download from the Apple App Store or Google Play Store). Adverse events should also be reported to Gilead to [email protected] or ‌+‌4‌4‌ ‌(‌0‌)‌ ‌1‌2‌2‌3‌ ‌8‌9‌7‌5‌0‌0‌.‌

TRODELVY®▼ (sacituzumab govitecan) Prescribing information for Great Britain

Trodelvy® Summary of Product Characteristics (Great Britain). Gilead Sciences Ltd. Available at: https://www.medicines.org.uk/emc/product/12880. Accessed: March 2024.

March 2024 UK-TRO-1527

Adverse events should be reported

For the UK, reporting forms and information can be found at www.mhra.gov.uk/yellowcard or via the Yellow Card app (download from the Apple App Store or Google Play Store). Adverse events should also be reported to Gilead to [email protected] or +44 (0) 1223 897500.